Advanced Treatment in PNH: Pegcetacoplan Study Breakdown

An insightful overview of paroxysmal nocturnal haemoglobinuria (PNH), introducing pegcetacoplan and its mechanism within the context of the PRINCE trial. Key findings highlight the drug's efficacy in stabilising haemoglobin, reducing LDH levels, improving haematologic parameters, and enhancing quality of life. The discussion extends to pegcetacoplan’s role in treatment strategies, its safety profile, and prospects for future research and clinical applications.